Association between initiation of sacubitril/valsartan and improved left ventricular ejection fraction in the real world

Back

HFA Premium Access

Association between initiation of sacubitril/valsartan and improved left ventricular ejection fraction in the real world

Session: Chronic Heart Failure - Treatment 1

Topic: Pharmacotherapy

Speaker: Professor L. Lund (Stockholm, SE)

Event: Heart Failure 2021

Congress Presentation

Add to my library

About the speaker

Professor Lars Lund

Karolinska University Hospital, Stockholm (Sweden)

61 presentations

10 followers

7 more presentations in this session

Short-term changes in left and right ventricular CMR feature tracking strain following ferric carboxymaltose in patients with heart failure: a substudy of the Myocardial-IRON trial

Speaker: Mr J. Nunez Villota (Valencia, ES)

Use of a portable elastomeric diuretic infusion pump to treat acute decompensated heart failure in an outpatient specialist nurse delivered multidisciplinary unit

Speaker: Doctor S. Brousas (Liverpool, GB)

Acute QRS narrowing following CRT implantation is associated with improved survival

Speaker: Mr D. Lapidot (Jerusalem, IL)

CardioMEMS reduce disease specific and all-cause hospitalizations, and lower mortality among patients with heart failure - A systematic review and meta analysis of incidence rates.

Speaker: Doctor D. Verghese (Chicago, US)

Validation of a novel framework defining the acceptable standard of care for heart failure with reduced ejection fraction

Speaker: Doctor P. Lopes (Carnaxide, PT)

Access the full session

Chronic Heart Failure - Treatment 1

Speakers: Professor L. Lund, Mr J. Nunez Villota, Doctor S. Brousas, Mr D. Lapidot, Doctor D. Verghese...

Access

About the event

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources